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There appear to he two ways in which a
drug can affect cells*, it may, in some way,
modify the function of the whole cell oy a
physicochemical process, e,g, by an action at the
cell surface*, it may affect only certain vital
processes (or even a single process), and in these
circumstances, the drug may only interact with
particular groups on or in the cell rather than
on the whole cell. The idea that drugs might
act in this second way was first suggested by
Langley (1378, 1905) and was used extensively by
Shrlich (1913) to interpret his results in
chemotherapy. This idea is important because of
suosequent discoveries in biochemistry and
physical chemistry (catalysis).
In enzymology, Michaelis and Menten
(1913) considered the adsorption of the substrate
at the "active spot" on an enzyme. Similarly,
in physical chemistry, Langmuir (1916, 1918)
regarded adsorption as due to the fact that a gas
molecule, striking the surface of the solid, will
tend to adhere to it for a period of time before
evaporating.
It was Clark (1933) who collected and
applied these ideas to the moue of action of
drugs. He obtained evidence which showed that
the molecules of some drugs cover only a fraction
of the total area of cells and suggested,
2.
therefore, that there were "active spots" on the
surface of the cell*, these "active spots",
where the drug acts, are called "receptors".
If the reaction between drug and
receptor is written
Drug 4- Receptor = Complex-> Breakdown-> Response
then the rate of formation of the complex will be
Ki[A](l--y), where [A] is the concentration of the
drug and y the proportion of receptors combined
with the drug. The rate of diseociatioii will be
K8y.




or it can be written
v = KaM , *(2)
1 ♦ Ka[A]
where Ka is the association ("affinity") constant,
i, e» Kj/Kg•
Michaelis an- Menten and Langmuir had
derived similar expressions.
Ks * (e " P)Csj Michaelis - Menten (3)
P
where e is the enzyme concentration, p is the
concentration of the complex, and [S] is the
concentration of the substrate. (It should be
noted that, whereas the enzymologist uses the
dissociation constant K = Kg/I^, the
O
3.
pharmacologist uses the association ("affinity")
constant = Kt/Ka.
Langmuir's expression can he written as
-0" = aU (4)
v + au
where "0" is the fraction of the total available
surface covered with gas molecules at any instant,
a is the proportion which adhere, u is the number
of gas molecules striking 1 sq.cm. of surface per
second, and v is a constant for the given gas
and surface.
Although the biochemist and physical
chemist can verify their respective expressions,
the pharmacologist cannot, because the steps
between the formation of the complex and
biological response are unknown. This led
Clark to make further assumptions (which he
pointed out were improbable ones in a
pharmacological reaction, although they were
true in enzymology) namely that the biological
response was directly related to the proportion
of receptors occupied, and that when all the
receptors were occupied there was a maximal
response"! when only 50^ of the receptors were
occupied there would be a 50?5 response.
Therefore in equation (1) when y = 0.5,
Ka « 1/[A] (5)
If this relationship were true, then
the affinity constant (K ) would "be the
cl
reciprocal of the concentration which would
produce half the maximal response. Some workers
(e.g. Ariens et al. 1954 and 195?) have used this
relationship in order to assess the affinity of
an agonist for the receptors. (other workers,
e.g. Stephenson, 1956, have shown that there was
no justification for this).
It may he argued that Clark's
application of the Langmulr Adsorption Isotherm
to drugs and receptors is valid because it can be
successfully used in problems in physical
chemistry and biochemistry (and the drug-receptor
concept is similar to these). Although Clark
used the Langmuir Adsorption Isotherm, he himself
pointed out that the results can just as easily
be interpreted by the Weber-Fechner law
Ky sis log(bA + l) (6)
or by the Freundlich equation
y = KA® (7)
In view of the empirical nature of
equations (6) and (?)» the Langmuir Adsorption
Isotherm is preferred because of its validity in
chemistry and biochemistry.
Clark and Raventos (193?) showed that
equipotent doses of acetylcholine and tetra-
methylammonium on the rat intestine, frog auricle
and frog rectus preparations could be antagonised
5.
to the same extent by many antagonists. Further,
although the concentration of tetramethylainmoniura
required to produce the same effect as
acetylcholine on the preparations was 1000 times
that of acetylcholine, these two compounds acted
additively, i.e. if a concentration a of
acetylcholine produced the same effects as a
concentration it of tetramethylammonium, then the
same effects were obtained with a/2 + t/2.
From the results of Clark and Raventos, it
appeared that the lower activity of
tetramethylammonium compared with acetylcholine
could be abseribed simply to a lower affinity for
the receptors. If the drug-receptor complex
produced by tetramethylammonium was less
effective than the complex produced by
acetylcholine, it would be expected that the
presence of tetraraethylammonium would be reducing
the number of receptors available for
combination with acetylcholine, and so the
effects of these two compounds would not be
additive.
These results gave rise to the
"all -or-none" theory of the drug-receptor complex,
i. e. the idea that the drug-receptor complex was
either completely effective or completely
ineffective. If it were effective, then the drug
would be an agonist^ if it were ineffective, the
drug would be an antagonist* In either case
the activity of the drug would depend only on its
adsorbability (affinity).
Although the results obtained by Clark
and Raventos for acetylcholine and tetra-
methylaffiaionium appear to support the
"all-or-none" theory, Ariens and de Groot (1954)
and Stephenson (1956) haye shown that other
compounds, e.g. some alkyltriraethylammonium salts,
act like acetylcholine on the guinea-pig ileum or
frog rectus preparations, but do not act additively
with acetylcholine. These compounds are called
"dualists" (Ariens) and "partial agonists"
(Stephenson) and in order to interpret this they
introduced a new factor which the former called
"intrinsic activity" and the latter, "efficacy".
Thus, they suggested that the activity of a drug
depends not only on its affinity (adsorbability)
but also on this new factor.
Stephenson goes further and points out
that there is no evidence that the response is
linearly proportional to the number of receptors
occupied, therefore he introduces the quantity S,
the stimulus given to the tissue, which is some
function of R, the response, i.e. R = f(S). vVe
do not know how the two are related. Stephenson
defines the stimulus (S) as the product of
efficacy ana the proportion of receptors
occupied,
i.e. S = ey (8)
From equation (2),
eK[Al
S . i (9)
1 ♦ K[A]
To compare the activity of two agonists
it is usual to measure the concentrations which
produce comparable effectsi
i.e. S = etyt = eay8
or » esKa [A2 ]
(10)
1 + K^CAi] 1 + K3[A2]
If the values of [A±], [Aa], Ki and Ka
were known, it would he possible to estimate the
ratio Qi/es. The absolute values of the affinity
constants of pure agonists are unobtainable since
they depend on knowing ej^ and e8, but they are
obtainable for antagonists by using the Saddum
equation (1937).
i.e. [A]/[a] * 1 + [B]Kb (11)
where the response to a concentration, [A], of
agonist in the presence of a concentration, [B],
of antagonist, is the same as that to a
concentration [a] of agonist alone: K is the
affinity constant of the antagonist.
The derivation of this equation makes
no assumptions about the relationship between
biological stimulus and proportion of receptors
occupied.
8.
When the "dose ratio", ([A]/[a]) is 2,
equation (11) "becomes [B] = 1/K,Q. Schild (1947)
calls log. 1/[B] "pAg", which is therefore log.
Recently, Paton (1961) has suggested
that excitation "by a stimulant drug is
proportional to the rate of drug-receptor complex
formation rather than to the proportion of
receptors occupied.
This "rate" theory differs only from
the "occupation" theory in that it uses k3, the
dissociation rate constant. In the "rate"
theory, the idea of "efficacy" (as meant by
Stephenson) is accounted for in the dissociation
rate constant.
Thus the mathematical relationship
relating dose and response is similar in both
theories:









where x is the dose, and K, kt and ka are constants.
Stephenson suggested that if two types
of series of compounds were prepared, one
antagonist and the other agonist, changes in
affinity with structure could easily be measured
in the antagonist series, and might "be applicable
to the corresponding agonists. Accordingly,









where R ia a 2~(diphenylacetoxy)ethyl,
2-(benziloyloxy)ethyl, 2-( 2,2-diphenylethoxy)ethyl»
3-(diphenylmetnoxy)propyl, or 3,3-diphenyl-
butyrylmethyl group and R* is a 2-acetoxyethyl,
2-ethoxyethyl, 3~methoxypropyl or butyrylmethyl
group. (R and R* are later referred to as the
"body of the molecule). The compounds of the
first type of series differ only from those of the
second type in that they contain a diphenylmethyl
(or a benziloyl) group in place of the methyl
group. The former compounds are antagonists of
acetylcholine whereas most of the latter were
acetylcholine-like.
Scott measured the affinity constants of
the antagonists and observed that similar
alterations in the composition of the "onium"
group produced similar changes in affinity in many
series of compounds. Scott then measured the
acetylcholine-like activity of the agonists and,
if it is assumed that the same changes in
10.
composition of the onium group produce similar
changes in the affinity of these agonists, as they
do in the antagonists, it then becomes possible to
assess the effects of changes in chemical structure
on the efficacy of these compounds. This
assumption seems reasonable because, from the
theory of Arrhenius, the relationship between the
affinity (association) constant, K» for the drug
and receptor, and the free energy change on
adsorption is
AP = -RTlog, K
©
or log.10K = (12)
3. 3RT
If it is assumed that the change in free
energy of adsorption depends only on the
substitution in the onium group, i.e. any
contribution from the "body" of the molecule is
unaffected by changes in the onium group, and if
+
we let the free energy of adsorption of RKMea be
F, and the free energy of adsorption of R'KMea be
F', then the free energy of adsorption of
+ +
RNMe2Et « AF +• a, R*:iMeaEt * AF* + a
+ +
RKMeEtg » AF + b, R'NMeEtjj = AF* + b
4- +
RREta » AF 4- c, R'NEtg « Ap» + c
where "a" is the change in free energy brought
4- 4-
about by replacing KMea by KMeaEt, "b" is the
+ 4-
change for replacing NMea by NMeEts and "c" is the
4- 4-
change for replacing HMea by NEta. The affinity
11.
constants for the antagonists can "be obtained
+
experimentally. For R'r e3 let it "be X, for
+ +
R?TMeaSt let it "be K , for RNMeEta let it be K^,
+
and for RNSt3 let it be K .
Hence log. K
and log. K












K /K =10 (14)
51
The values for -a should be the same and
likewise those of -b and -c (similarly determined)
regardless of the nature of the "body" of the
molecule. With a few minor exceptions, which he
attempted to explain, Scott (1963) found this to
be true for all the series of antagonists he
studied. Therefore, since the change in free
energy of adsorption depended only on the
substitution of the onium group and not at all on
the body, the ratio K /K (obtained by experiment)
for the antagonist series can be transferred to
the corresponding agonist series.
Let us suppose that the two agonists
+ +
R*KM®a and R#NMeaEt have affinity constants K*
and K* respectively and that the equipotent molar
If the drug 1b a highly active agonist,
the work of Nickerson (1956) on the histamine
receptors of the guinea-pig Ileum and of AriUns
et al. (i960) on the acetylcholine receptors of
the guinea-pig ileum (and the adrenaline recept¬
ors of the rabbit aortic strip) Indicates that
the proportion of receptors occupied is small.
In these circumstances it is justifiable to
calculate the efficacy ratio as above. If,
however, the compound has a much lower efficacy,
the proportion of receptors o ccupied may be
large, and the efficacy ratio cannot be calcula¬
ted from these results. It may be apparent,
if the efficacy is very low, because the compounds
fail to produce a maximal contraction however
much is given, but it is still possible that
there are many compounds with low efficacy which
are capable of producing maximal responses of
the tissue and give dose-response curves parallel
to those of acetylcholine. It is clearly not
justifiable to use the approximation to calculate
changes of efficacy with structure in these
compounds.
If a compound, is weakly active it is likely
that it has a low efficacy rather than a low
affinity (Scott et al. , 19&3) hence falls
into this category. It is therefore unwise
to attach too much importance to relationships
between structure and apparent changes in effi¬
cacy of series of weak agonists. It does not
follow that more active agonists have a higher
efficacy and are not occupying a large proportion
of receptors, though (again from the work of
Scott aj,. ) it seems more likely that similar
compounds are active because they have a reason¬
able efficacy than because they have a very
high affinity. This present work depends upon
the expectation that this is correct.
In order to check this it would be necessary
to repeat experiments such as those described




ratio of R*KM®sEt relative to RfKMe3 is n, i.e.
n molecules of the former are needed to produce
the same response as the latter, then from
equation (11) we have
eK«[Aj = e^Aaj
1 + K*[A] 1 + Kq[Aa] (15)
■i*
where e is the efficacy of R'nMes and [A] is the
concentration producing the response^ e is thef*
+■
efficacy of R'NM«8St and [A&] is the concentration
producing the same response. Hence [A l/[Aj = n.
If the proportion of receptors occupied
toy the drug is small, the expression K '[A] =
—*— approximates to y, therefore the stimulus
y - 1
S = ey = K*[A]. Equation (15) then "becomes,
eK«[A] =




If the assumption is correct then the
ratio K /K (for the antagonists) will toe the same
a
as the ratio K'/K* (for the agonists). Although
a
the efficacy cannot toe calculated, the effect on
efficacy of a change in composition of the onium
group can toe calculated from equation (16), since
the affinity constants of the antagonists and n
for the agonists can toe determined experimentally.
13.
The purpose of the present work is
two-fold:
(i) To repeat some of Scott's work in
order to check on the sort of errors which may toe
involved in the method, and to extend some of his
series. The affinity constants of the
antagonists in the diphenylacetoxyethyl and
toenziloyloxyethyl series were redetermined and
these two series were extended toy introducing
ring structures into the onium group,
where R is diphenylacetoxyethyl (PhaCH. CO. 0. CHaCHa-)
or toenziloyloxyethyl (PhaC(0H). CO.0. CH3CHa-) and
R' is methyl or ethyl.
The corresponding agonists (where R =





(11) To synthesise some series of
cyclic compounds and study their pharmacological
properties in a similar manner to that of Scott.
An attempt was made to prepare the
following cyclic series:










When R" = diphenylmethyl the compounds
are antagonists and when R" * methyl the compounds
are agonist si a = 0 or 1.
15.









The effects on affinity and efficacy
of altering the onium group can he studied and
hence, since there are several series of compounds,
it should "be possible to see whether similar
changes in composition of the onium group produce
similar changes in affinity.
Alternatively, the effects on affinity
and efficacy of altering the 'body" of the molecule
can "be studied although it is perhaps not
justifiable to do this since, in addition to a
change in size and shape of the ring ("between five
and six-membered rings), there are positional
changes which have to be considered. This could
lead to all kinds of complications from which it











































All experiments were performed on the
isolated guinea-pig ileum preparation.
A guinea-pig, weighing about 200-250g.,
was killed by a blow on the head and bled out.
About 10cm. of ileum was carefully dissected
out and placed in a dish of Tyrode solution
(at about 25°C). The lumen of the gut was
washed through*, care was taken to distend th©
gut as little as possible. The terminal 2 cm.,
containing the Peyer's patch, was removed, and
the adjacent 3cm. of the ileum was suspended in
Tyrode solution in an organ bath of 2.5ml.
capacity for agonist assays, and in one of 5.0ml.
capacity for antagonist assays^ The gut was
attached to a light isotonic frontal writing
lever giving a magnification of five and with a
load of 0. 5g.
The organ bath was connected to coils
of glass tubing so that the fluid in the bath
could be replaced by upward displacement and
overflow, either by Tyrode solution alone or by
Tyrode solution containing drugs at predetermined
concentrations. The coils were kept at
37 - 0.1°C in a thermostatically controlled bath,
The Tyrode solution used in all
experiments contained double the normal
concentration of potassium because it had been
17.
found by Scott (196S) that the responses to a dose
of drug were more regular In these conditions.
In particular, in antagonist assays in which the
same dose is given five successive times, the
response became constant much more rapidly
(e.g. after only 2 or 3 contractions) when the
Tyrode solution contained double the normal
concentration of potassium. The Tyrode solution
also contained hexamethonium bromide (1.1 x 10 M)
to ensure that the drugs were acting only on the
postganglionic cholinergic receptors. In some
_7
experiments Mapyraralne (4.0 x 10 M) was also
present in the Tyrode solution in order to
prevent a response caused by action on Histamine
receptors. However, the presence of Mepyramine
in the Tyrode solution appeared to have no effect
whatever on the responses.
The antagonist assays were performed by
an automatic apparatus similar to that described
by Sehild (1947), and the agonist assays were




Antagonist activity was estimated by
determining the affinity constant (K^) of the drug
for the acetylcholine receptors in the tissue.
A response was obtained with
9
acetylcholine (usually 4.4 x 10 M applied for
10 or 15 seconds) and then washed out with about
20ml. of Tyrode solution. This was repeated at
intervals of 60 or 90 seconds until the
contractions became steady, usually after about
an hour.
In all the experiments it was found that
three concentrations of acetylcholine, that is,
ja
2.2, 4.4, and 8.8 x 10 M, which produced
between 20 and Q0% of the maximal response, were
always satisfactory. A group of five
contractions was obtained with each concentration
and the groups were repeated a number of times in
a random order. When the responses to each
concentration appeared to be regular (i.e. there
was little variation between groups for a
particular concentration) a final group of
responses was obtained with the low concentration,
then with the high concentration, then with the
intermediate concentration, and lastly with the
high concentration*, this sequence was used by
Scott for his antagonist assays. From these
19.
results for low and intermediate concentrations,
and from the last results for the high
concentration, a graph of log. dose against
response was plotted.
After the last response was obtained
with the high concentration of acetylcholine, the
Tyrode solution -was replaced by Tyrode solution
containing antagonist. The agonist solutions
were replaced by another solution containing a
much higher concentration of acetylcholine (of
the order of 10 M) together with the same
concentration of antagonist as was present in
the washing Tyrode solution. The actual
concentrations of antagonist and agonist were
those which, from preliminary experiments,
seemed likely to produce a response about the
same as that given by the intermediate dose of
acetylcholine alone. This solution (containing
both agonist and antagonist) was applied
repeatedly to the ileum, until such time as five
contractions of the same height were obtained,
indicating that equilibrium had been reached.
A higher concentration of antagonist,
with a correspondingly increased concentration
of acetylcholine was then used instead of the
previous solutions, and the process repeated.
The procedure was repeated a third time using
still higher concentrations of agonist and
It was assumed that the sensitivity
of the tissue did not alter during exposure to
the antagonists. If it did, an incorrect dose
ratio would he obtained. In all the experiments
the graph of cose ratio - 1 against antagonist
concentration was found to be linear and the
values of were reasonably consistent s if
changes in the sensitivity did occur they must
have occured to about the same extent in all the
experiments. Though this could be true if all the
experiments had taken the same length of time to
perform it seems unlikely because some experiments
were performed more rapidly than others and did
not appear to give abnormal results.
20.
antagonist.
A typical assay is shown in Figure (i)
and the graph of the log. aose (agonist) against
the response plotted, as shown in Figure (ii).
When the graph was not linear a straight line was
drawn joining the two points between which lay
the response produced in the presence of the
antagonist. The graph was used to estimate the
concentration of agonist which alone would
produce the same response as was obtained by the
(higher) concentration of agonist in the presence
of antagonist. The ratio of the two
concentrations of agonist (i.e. the dose ratio)
is a measure of the antagonism produced by the
particular concentration of antagonist: the
affinity constant could then be measured by
substituting the observed value of this dose ratio
into the Oaddum equation,
i.e. [A]/[a] -1 = 3^ (Equation 12)
As three concentrations of antagonist
were usually used, a graph of (dose-ratio - 1)
against concentration of antagonist could be
plotted (Figure iii) and this should be linear if
the antagonism is competitive. This was always
found to be so.
^ It was usually found that it was
necessary to use about five preparations, each of
21#
which afforded three results, in order to obtain
a mean value with reasonably narrow fiducial
limits#
Figure (i)
A typical assay used to determine the
affinity constant of an antagonist.
Ai = 2. 2 x 10 8M acetylcholine
Aa = 4.4 x 10 M acetylcholine




—1 -84.4 x 10 M acetylcholine + 6.0 x 10 M antagonist
2. 2 x 10 8M acetylcholine + 3.0 x 10 7M antagonist
4.4 x 10 8M acetylcholine + 6.0 x 10 antagonist
The antagonist under test is















1. ABt 8. 7575 5.72 X
2. ABa 8. 7600 5. 75 X
3. ABa 8. 7700 5. 89 X
From the Gaddum equation, = [A/a. — 1] / B
Hence,
1.
4. 4 x XO
5.72 x 10
-3








- 1 / 3 x 10-7
1. 24 x 10
8
3. 4. 4 x 10
5.89 x 10
—8
- 1 / 6x10'
1.23 x 10 8
Mean value of affinity constant is 1. 20 x 10
8
—8
Antagonist concentration (x 10 )
Graph of ( dose ratio - 1) against antagonist concentration




Agonist activity was estimated by
determining the equipotent molar ratios, relative
to acetylcholine, as described by Stephenson
(1956).
Preliminary experiments were performed
by adding the agonist to the organ bath from a
pipette, in order to determine what
concentrations of drug were needed to produce
between SO and 30$ maximal contraction of the
ileum. Acetylcholine was added in a similar
way and the log. dose - response curves for it
and for the test compound were plotted: these
were normally found to be parallel, e.g.
Figure (iv).
From these experiments it was possible
to calculate an approximate equipotent molar
ratio for the agonist, relative to acetylcholine*,
hence 2+2 dose assays were performed.
The four different agonist solutions
were used in varying order to produce forty-eight
contractions (twelve groups of four, arranged in
three Latin squares), i.e.




The dose order is so arranged that each
23.
dose is preceded "by all other doses the same
number of times', thus it was hoped that the
effect that a boee had, on the one following it,
would not be likely to bias the results.
However, it was observed that a large dose will
usually increase the size of contraction of a
following large dose, but diminish the size of
contraction of a following small dose. In an
attempt to modify this effect a third dose of
acetylcholine was interpolated between each of the
assay doses as described by Scott (1962). There
did not seem to be any significant difference
between an assay with an interpolated dose and
an ordinary assay in my experiments, although
Scott observed one in his experiments.
The two doses of acetylcholine used
*mQ
were usually 2.2 and 4.4 x 10 M although it was
sometimes necessary to use higher or lower
concentrations depending on the sensitivity of the
preparation. The drugs were added every 60 or
90 seconds (this interval depended on the time
taken for the ileum to relax after a wash with
Tyrode solution, but it was the same interval for
a complete assay) and they were left in contact
with the ileum for 10 or 15 seconds.















"8.7 8.8 8.9 7.0
Log. dose of acetylcholine
6.7 6.8 6.9 5.0
Log. dose of test compound
CHa . CO. 0. CHa. CHa\




A typical 2 + 2 dose assay
The four different agonist concentrations (two of
acetylcholine and two of the test compound)
were added in varying order to produce forty-
eight contractions (twelve groups of four
arranged in three Latin squares) as described
on page 22.
—5
A = 0.5 x 10 M test compound
B = 4. 4 x 10 8M acetylcholine
C ? 8.8 x 10 8M acetylcholine
_5D = 1.0 x 10 M test compound
The test compound was






The affinity constants of the
antagonists are shown in Tables I to V.
Scott's results with the compounds
of the diphenylacetoxyethyl and benziloyloxyethyl
series are included in Tables I and II for
comparison. I have also included results
obtained by N. C. Scott along with my own in these two
Tables.
The affinity constants of the
diphenylacetyl esters of a and (3-hydroxymethyl-
pyrrolidine (Table III), p-hydroxypiperidine
(Table IV) and p-hydroxymethylpiperidine (Table V)
derivatives are very similar to those of the
diphenylacetoxyethyl series (Table I), i.e. of the
7
order of 10 . The affinity constants of the
benziloyl esters (Table II) are much higher, being
s
of the order of 10 , but those of the
diphenylacetyl esters of Y~hydroxypiperidine
derivatives are higher still, and of the order of
9
10 .
The standard errors attached to the
estimates of the affinity constants of the




















































































































































































































































































































































































































































































































































































From the values in the Tables it is
possible to calculate either the effect on affinity
of changing the composition of the onium group or
of changing the composition of the body of the
molecule", this is explained in the introduction
(page 7 ).
The ratios of the affinity constants are
shown in Tables Via to IX. The fiducial limits
for these ratios can be calculated by assuming a
normal distribution of the values of the
logarithm of the affinity constant (G-addum 1939,
1953). The logarithm of the ratio K /K is the
a
difference of the two means, i.e. log.K - log.K,
a
where K is the affinity constant for the compound
St
where the change has been made (e.g. replacement
of methyl by ethyl in the onium group) and K, the
affinity constant for the standard (e.g. the fully
methylated compound).
The scatter of individual values of
log. K about the mean, log. K , will be given by
£di3
the variance ^ ^ and similarly the scatter of
individual results of log.X about the mean,
£da3
log. K, will be given by the variance ,»
Ilg "" X
where d1 and da are the deviations of values of
log. K and log. K respectively, from their
a
respective means (i.e. log.K and log.K!), and %
a
and n3 are the number of experiments used to
determine the mean values.
31.
If It is also assumed that the variance
arises from the same source in all experiments,
it is reasonable to pool all the estimates of the
variance. Hence the variance for individual
results will "be given by
s» - £a.t' *£d,' ♦.
% - 1 + na - 1 + % -* 1 +•
where the denominator is the number of degrees of
freedom for all the experiments.
Hence the variance of M (i.e. log.K /K)81
is given by
where n. is the number of results on which K is* a
based and n3 the number of results on which K is
based.
Fiducial limits of M are obtained by
applying the 't* distribution for the total number
of degrees of freedom (the level of probability
chosen was 95%), i.e.
Vj - M1 \/B" [\
In fact, the variance for the experiments
with the diphenylacetoxyethyl and benzilyloxyethyl
series was calculated separately from the other
experiments.
In the former 257 experiments were
performed with 3,b compoundsi hence there are 221
degrees of freedom. The sum of the (^>ds) terms
for these sixteen compounds was 0.616015 and thus
32.
the estimate of the variance is
g3 = 0. = p. QQ8787
In the latter 173 experiments were
performed with 10 compounds^ hence there are
163 degrees of freedom. The sum of the (£d2 )
terms for these ten compounds was 0.195585 and thus
the estimate of the variance is
ss = 0.= 0,0012
The affinity constants of the
aiphenylacetoxyethyltrimethyl ammonium "bromide
(K) and diphenylacetoxyethyldimethylethyl ammonium
hromide (K„) may "be obtained from Table I,ci
i.e. K = 3.83 x 107 [20 results]s.
K « 1.45 x 107 [12 results]
Thus, log.K = 7.577 and log.K = 7.157
0
and M = log. [K /K] = 0.4200
* +i
n^L nav[m] = s2
= 0.002737 [0.83 + 0.050]
= [0.01925]2
For 221 degrees of freedom, t (at the






= 0.420 - [1.96 x 0.01925]
= 0.420 - 0.0377
In a dition, the tables show the changes
in free energy of adsorption of the compounds
(with 95% confidence limits). These are obtained
33.
fey substituting the values of log. K /K into
9.
equation (13), i.e.
-f = -a = 2. 3HTlog. [Ka/K]
= 1417 log. [Kfi/K]
since R = 1.987 cal./deg./mole and T = 37°C =
310°A.
The effect on affinity of a change in
composition of the onium group (replacement of








( 2. 41) (0.332) (541)
NM«sEt 0. 420 595
( 2. 87) (0.453) (649)
( 2. 36) (0.372) (527)
NMeEt 2 2.61 0. 416 589
(2.88) (0. 460) (652)
4-
(1. 47) (0.167) (237)
NEta 1.62 0. 209 296





















(2. 74) (0.438) (621)
ca (1.14) (0. 062) (88)















ote : The variance used in calculating the
results in this Table anc in Tables
VIb, Vila and VIIo is 0.002787.
35.
TA8LE '/lb
Effects on affinity of replacing
N-mcthylpyrrolidinium (K) "by -ethylpyrrolidinium
(K^) and I -methylpiperidinium "by K-ethylpiperidininm
in the diphenylacetoxyethyl series.
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Effects on affinity of replacing
K-methylpyrrolidinium (K) by I -ethylpyrrolidinium
(K^) and N-methylpiperidinium by IT-ethylpiperldinium
in the benziloyloxyethyl series.



























DIPHENYLAOETOXYf.lKTHYL-PYRROLID I I"I UM SERIES








(1. 47) (0.167) (237)
a 1. 54 0.183 266
(1.62) (0. 209) (296)
(1. 44) (0.158) (224)
P 1.52 0.181 256
(1. 60) (0.204) (289)
Kote : In this, and subsequent Tables, the










KaA log. Ka/K -f
(1.28) (0.106) (150)
3 1.35 0.131 186
(1.43) (0.156) (221)
(0.98) (1.991) (-13)
T 1.04 0. 015
(1. 09) (0.039) (55)
(0. 65) (X.814) (-263)
r* 0. 69 1. 838 -229
(0.72) (1.862) (-195)
& This was the only instance where both
methyl groups in the onium group were
replaced, in all other instances the
change in the onium group is replacement




The equipotent molar ratios, relative
to acetylcholine, are shown in Tables X to XII.
With the exception of acetoxyethyl-i>
methyl pyrrolidinium iodide, the compounds are
all less than one tenth as potent as acetylcholine#
The standard errors attached to the
estimates of the equipotent molar ratios of the
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0 Me Me 1,594 1,703 3
1,698 (il2)
Ud.
From the equipotent molar ratios of the
agonists and the affinity ratios of the
antagonists (Tables Via to IX) it is possible to
calculate the effect on efficacy of changing the
composition of the onium group or of changing the
composition of the body of the molecule*, this is
explained in the introduction (equation (16),
page 12),
i.e. e/ea = n[Ka/K]
The effect on efficacy of a change in
composition of the onium group (replacement of










K /Ka' e/e„' a
NR Acetylcholine a h a D
N+
/ \Me N 3. 5 1.91 1.19 16. 2 10.1
11+
/ \
Et N 217 2. 51 1.39 545 302
r~\
A+ /Me N ' 3,414 1. 25 0. 33 4,268 1,297
/ \
11+ /
si V—/ 15,196 0.72 0, 42 10,941 6,382
Results in column a are derived from experiments with






















1.0 1.0 1.0 1.0
/
/!1\Et N 2. 6 1. 32 1.1? 3.4 3.0
/],0Me x' 1.0 1.0 1.0 1.0 1.0
/— \
/N\ /St N ' 4.5 0.58 1. 10 2.6 5.0
Results in columns a and to for K /K values are
a








ratio relative to Ka/K e/eato ring Ach. dimethyl
analogue
a Me Me 2,926 1.0 1.0 1.0
a Me Et 11,033 3.8 1. 54 5.8
3 Me Me 871 1.0 1.0 1.0
13 Me Et 1,251 1.4 1.52 2.1









ratio relative to K /K
a e/®a
to ring Ach. dimethyl
analogue
e Me Me 156 1.0 1.0 1.0
0 Me Et 8,857 56.8 1. 35 76.7
r Me Me 77.0 1.0 1.0 1.0
r Me Et 4,719 61. 3 1.04 63.8
The values for the ratio K&/K are obtained from Table IX,
discussion
As indicated on page 9 many of the
compounds can be regarded as being made up of an
onium nitrogen atom, with a number of simple
alkyl eubstituents (methyl or ethyl groups), and
a much more complicated fragment (shown as R or R*
on page 9) such as a diphenylaeetoxyethyl or
benziloyloxyethyl group. This latter 8 or H' is
referred to as the *body' of the molecule.
The cyclic compounds can toe divided,
into two groups. In the first, two of the simple
alkyl groups (methyl or ethyl) on the onium atom
can toe regarded as having toe n transformed into a
] and the more complicated
/
ring | e.g. R -
?4ev
part of the molecule, R, is again referred to as
the 'body*. In the second type of cyclic
structure the ring replaces only one of the
simple alkyl substituents in the onium atom and
the term *oody' is used to describe all the rest
of the molecule apart from the two remaining
alkyl groups and the onium nitrogen atom. The
'cody' of the molecule in these molecules is thus
attached to the onium atom at two points : for
instance, in p-aeetoxy- -.'-dimethyl piperidinium,





This discussion will he divided into
two sections.
tlle first section I intend to
discuss the effects that changes in the
composition of the oniura group have on affinity
in the dlphenylacetoxyethyl and benziloyloxyethyl
series and then to consider the effects, on
affinity, when the diphenylaeetyl part of the
molecule is replaced "by benziloyl.
The activity of the correspending
agonists (only those with cyclic structures in the
onium group) will then be discussed, and from the
information obtained here, and from the results
obtained above about changes in affinity in the
antagonist series, deductions will be made about
the efficaey of the agonists.
second section I intend to
consider the effects on affinity, of changes in
the "body" of the molecule (i.e. changes in the
size of the ring and the position of the
substituents) and of changes in the onium group in
the series of compounds (shown on page 14) in which
the -CHa~GHa- part of acetylcholine is
incorporated in a cyclic structure or in the side
chain of the ring.
Prom the conclusions obtained here
and from results obtained about the activity of
the corresponding agonists, deductions will be
51.
made about the effects these changes have on
efficacy.
It had "been hoped to prepare the fully
ethylated compounds in these series but
unfortunately only one of them ( -diethyl~y~




Effects on affinity of oranges
in the composition of the onium
group in the olphenflacetoxyothyl
■and 'Deri2iloylox.yeth.yl series.
At a level of probability of 1 in 100
there is no significant difference between
Scott's (1965) results and mine (which include
H. C. Scott's results) for the oiphenylaeetoxyethyl
and oenziloyloxyethyl series (Tables I and II),
but at a level of probability of 1 in 20 the
results for the dimethylethyl and diethylmethyl
compounds in the ciphenylacetoxyethyl series are
significantly different. Apart from these two
minor differences it can be concludec that
Scott's results are reproduceable.
In both these series the affinity
constant of the dimethylethyl compounds was about
2.5 times that of the fully methylated compound.
Further replacement of a methyl group toy an ethyl
group in the onium group caused a slight increase
in the affinity constant, but the value of the
affinity constant of the fully ethylated compound
was only slightly greater than that of the fully
methylated compound. Scott found that this sequence
was reproduceable in other series that he tested.
It was therefore thought that further changes in
the composition of the onium group would produce
similar changes in the affinity constants of
53.
compounds in the diphenylacetoxyethyl and
toenziloyloxyethyl series. The changes that
♦
were made were the introduction of N-methyl
♦ ♦
pyrrolidinium, N-ethyl pyrrolidinium, N-methyl
+
piperidinium and IT-ethyl plperidinium groups
respectively.
The pyrrolidinium compounds have quite
a considerable affinity which is increased toy
replacement of methyl toy ethyl. On the other
hand the plperidinium compounds have a lower
affinity, which in the diphenylacetoxyethyl
series is decreased toy replacement of methyl toy
ethyl, whereas in the benziloyloxyethyl series
there is a slight increase (not significant at a
level of probability = 0.05).
The results for tooth these series are
shown pictorially in Figure (vi) where the
logarithms of the affinity constants of the
members of the two series are plotted against the
composition of the onium group.
If the effect of change in composition
in the onium group is really independent of the
nature of the "body" of the molecule, then these
lines for the two series should toe parallel.
This is quite strikingly true for the
compounds studied toy Scott (and which have been
repeated) tout for the cyclic compounds there are






















Composition of the Onium group
5U.
ascribed to experimental error. These
discrepancies imply that by introducing the ring
into the onium group there is some interference
with the binding of the molecule to the receptor.
This could be brought about by :
a) Reduced flexibility of the molecule
b) Intramolecular forces
c) Decreased binding of onium group
because it is bigger.
a) Reduced flexibility of the molecule.
It might be that the ring reduces the
flexibility of the molecule hence making it more
difficult for the groups within the molecule to
combine with the receptor groups. As might be
expected this effect was greater with the bulky
six-membered ring than with the five-membered
ring. It might be possible to detect this
effect by studying the infra-red spectra of these
compounds, since adsorption depends on the energy
required to produce rotation and vibration of
groups within the molecule, and, in this case the
adsorption will be reduced if the groups are less
flexible.
b) Intramolecular forces.
There may also be intramolecular forces
between certain groups in certain molecules which
would reduce the binding of the molecule to the
receptor (e.g. there might be an interaction
55.
"between the cationic head and the hydroxy! group
in the beriziloyloxyethyl series).
e) Decreased binding of onium group because
** Iff, bigger*
When the cationic head is very large
(as in the cyclic compounds) the electrostatic
force binding it to a negative centre on the
receptor will be much weaker if it obeys the
inverse square law.
Apart from these discrepancies the
changes of free energy of adsorption brought about
by replacing the fully methylated onium group by
the dimethylethyl or diethylmethyl onium group in
both series are of the order of 0. GKcalories*,
this suggests that the increased affinity
involves van der Waal's binding of a methylene
group, in the onium part of the molecule, to the
receptor.
56
affects on affinity of replacing
the diphenylacet.yl part of the
molecule by benziloyl.
The benziloyl esters all have a greater
affinity for the receptors than the diphenylacetyl
esters^ this is in agreement with Ac red et al.
(1957). This difference in affinity between the
benziloyl esters and the diphenylacetyl esters
corresponds to a difference in free energy of
adsorption of about 2 Kcalories for the compounds
with simple alkyl groups substituted in the onium
group and about 1 Kcalorie to 1.6 Kcalories for the
compounds in which there is a cyclic structure in
the onium group. This suggests that there is
hydrogen bonding between the hydroxy! group in the
benziloyl part of the molecule and the receptor
with the compounds with simple alkyl groups
substituted in the onium group. When the onium
group contains the bulky cyclic structure the
binding is much weaker for reasons already
discussed on page 54,
affects of Introducing: cyclic
structures Into the onluro group
on the activity of members of the
acetoxyethyl seri.es>
It is possible that the agonist
activity of the compounds tested could arise from
actions at the parasympathetic ganglia or at
receptors other than those affected by acetyl¬
choline ( such as histamine or 5-hydroxytryptamine
receptors). An action at ganglia, however, is
unlikely because hexamethoniua was present
throughout the experiments. The responses of the
compounds were not antagonised by mepyramine and
so are unlikely to be caused oy actions at the
histamine receptors, but they were antagonised by
atro ine which is consistent with an action at
acetylcholine receptors (though it does not
entirely rule out an action at 5-hyuroxytryptamiae
receptors^
As the sise of the cyclic oniun group
increases, the equipotent molar ratio (relative
to acetylcholine) increases $ that is, the
activity of the agonist decreases. The Ti-methyl
pyrrolidinium compound has some activity which is
reduced by replacement of methyl by ethyl, while
the piperidinium compounds are only feebly active.
58.
affects on efficacy of changes
in composition of the cyclic
onium group.
As I have already pointed out (page53 )
♦
the effects on affinity of replacing NMea by
♦ ♦ ♦
KMe3Et, NMeEta or NEta were similar in both the
diphenylacetoxyethyl and benailoyloxyethyl series,
+
but the effects on affinity of replacing NMea by
+ +•
N-methyl pyrrolidinium, N-ethyl pyrrolidinium,
+ ♦
Ii-methyl piperidinium or H-ethyl piperidinium are
significantly different in the different series of
antagonists, and so it is not really known what
effect these latter changes have on the affinity
of the agonists.
If the changes in the affinity constants
for these antagonists can be applied to the agonist
series the results (TableXiVci) suggest that the
+ +
replacement of NMes by K-methyl pyrrolidinium
reduces the efficacy to somewhere about 1/lOth to
l/16th that of acetylcholine and the replacement
of NMea by N-ethyl pyrrolidinium reauces the
efficacy to somewhere about 1/300th to l/550th»
Although it might he questioned whether the ratio
of the affinity constants is the same in the
agonists as it is in the antagonists, unless it is
wildly different, it is clear that the presence of
a five-membered ring in the onium group lowers
efficacy considerably and that the presence of a
59.
six-membered ring has a drastic effect on
efficacy, because, although the antagonists have




Effects on affinity of changes In
the size of the ring and position
of the subetituents in the cyclic
series.
The quaternary salts of the
diphenylaeetyl esters in the a and 0-
hydroxypyrrolidine, 0-hydroxypiperidine and
0~hydroxymethylpiperidine series all have affinities
of the same order as that of diphenylacetylcholine,
though the affinity of the 0-substituted compounds
is slightly higher than that of the a~substituted
compounds. On the other hand the quaternary
salts of the diphenylacetyl esters of
Y-hydroxypiperidine have a quite outstanding
affinity (about 200 times that of
diphenylacetylcholine) and comparable with that of
atropine. Perhaps this might have been
anticipated when one considers that they are
structurally similar to atropine, (In fact, if
the benziloyl esters of the quaternary salts of
Y-hyaroxypiperidine were prepared, then it would be
expected that they would have an extremely high
affinity).
If one of the series is chosen as a
standard and all the other series compared with it,
then it is found that the effect on affinity of a
change in composition of the "body" of the molecule
is similar within each series but there is a
61.
significant difference between each aeries# This









K = 1. 24 x 107
Me Et
K = 1,68 x 107

















2.65 X 107 2.13 464







In the column headed K the "upper" number In
+
each series is the affinity constant for the NMea
compound while the "lower" number is the affinity constant
4-
of the KlfeEt compound
63.
The p-substituted hydroxypiperidine
series were chosen as the standard because the
affinity constants of the members of this series
were very similar to that of diphenylacetylcholine.
It might be unjustifiaole to draw any conclusions
from the changes in free energy of adsorption
associated with the change in the "body" of the
molecule (TableXVU) because the series do differ
from the standard series not only in the
constitution of the "body" of the molecule but
also (to some extent) in the orientation of the
substituents of the onium group relative to the
rest of the molecule; consequently, the changes
in free energy might be due either to the
different orientation of the onium group, or to the
different constitution of the "body" of the molecule.
If it is assumed that the contribution to the change
in free energy from the different orientation of
the onium group is small compared with the change
in free energy involved in the change of
constitution of the body of the molecule then it
appears that in the Y~hydroxypiperidine
derivatives there might be hydrogen bonding
(about 3 Kcalories) between the carbonyl group in
the molecule and the receptor. This might be due
to the onium group and the ester group being in a
better position relative to each other than the same
groups are in the other series for binding with
the receptor.
6i+.
Effects on affinity of changes in the
composition of the onium group in the
cyclic 3eries.
Replacement of methyl by ethyl in the
onium group causes an increase in affinity. The
change in free energy brought about by replacing
NMea by NMeEt is about 0.2 Kcalories to
0.3 Kcalories in the quaternary salts of the
diphenylacetyl esters of a and (3-hydroxymethyl-
pyrrolidine and 3-hydroxypiperidine which suggests
that the methylene group in the onium group is
being bound by a similar force in these series.
On the other hand the change in free energy brought
4* +
about by replacement of NMes by JIMeEt in the
quaternary salts of the diphenylacetyl esters of
the Y-hydroxypiperidine series is very small and
suggests that the binding after substitution in
these molecules differs from what it is in the
other series possibly because of the orientation
of the groups within in the molecule (pag©63 ).
The affinity constant of F-diethyl-y-
(diphenylacetoxy)piperidinium iodide has also
been determined and it was found that although the
4*
affinity constant had increased when EMes was
4" 4•
replaced by 1'MeSt, it decreased when I Mea was replaced
+
by NEts.
Prom this work it appears that the
effects on affinity of a chemical change; in the
65.
structure of the oniura group are different in the
cyclic series from what they are in the series
studied by Scott (1963). Moreover, the effects
on affinity are different in some of the cyclic
series from what they are in others. This is
shown in the following Table, where the chemical

















In Scott's series a chemical change in
the onium group produced roughly the same change
in affinity in five series of antagonists. The
results obtained in this work (TableXVin) can be
explained by supposing that the orientation of the
substituents in the onium group relative to the
ester group is likely to be quite different in a
rigid ring structure (more so when it is a
piperidinium ring than when it is a pyrrolidinium
ring) from what it is in a flexible straight-chain
compound (Scott's series).
68.
Effects of changes In the size of
the ring and position of aubstltuents
on the activity of agonists in the
cyclic series.
The equlpotent molar ratios of the
agonists in the five and six-membered ring series
are all relatively high compared with
acetylcholine, i.e. the compounds are only feebly
active. The r-substituted compounds appear to be
the most active, the ^-substituted compounds less
active, while the a-substltuted compounds appear to
have virtually no activity.
Effects on efficacy of changes in
the size of the ring and position
of substituentB in the cyclic
series.
Prom the equipotent molar ratios of the
N-dimethyl and N-methyl-N-ethyl derivatives of the
cyclic compounds relative to N-dimethyl-0-
(acetoxy)piperidinium iodide and K-methyl-S-ethyl-
0-(acetoxy)piperidinium iodide respectively (i.e.
the corresponding agonists of the antagonists
chosen as standards for TableXVII), and from the
ratio of the affinity constants obtained in
TableXVH, it is possible to assess the effects on
efficacy of changes in the size of the ring and
69.
and position of subetltuents In the cyclic series.

































From these results it appears that a
six-membered ring is associated with a lower degree
of efficacy than a five-membered. ring. It is
particularly interesting to find that a high
affinity, e. g. as in the yhydroxypiperidine
series, is not associated with a high degree
of efficacy.
72.
Effects of changes in composition
of the onlura group on the activity
of the agonists in the cyclic series.
The replacement of methyl by ethyl in
the onium group decreases the activity of the
agonists considerably.
Effects on efficacy of changes in
composition of the oniurrt group in
the cyclic series.
Although there may be no justification
for transferring the ratio of the affinity
constants from the antagonist series to the
corresponding agonist series, it appears that,
unless there is some very considerable difference,
replacement of methyl by ethyl in the onium group
markedly reduces efficacy.
In the a-substituted pyrrolidinium
series the change in the onium group causes a
six-fold decline in efficacy, whereas in the
^-substituted pyrrolidinium series the decline is




Although I have made a number of agonists
which appear likely to have an affinity comparable
with that of acetylcholine, none of these appear
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oSKISO r al Ra. C. R\ C0. 0. (CHa )a. N+
>i»
R R' R" x~
H H Me i
H H St I
Ph H Me I
Ph H St I
Ph OH Me Br
Ph OH St Br
77.
ssRias I3L Rg • C# R'. CO* 0. (CHji )





H H Me Me P 0
H K Me St P 0
Ph H Me Me P 0
Ph H Me St P 0
H H Me Me Y 0
H H Me St Y 0
Ph H Me Me Y 0
Ph H Me St Y 0
Ph H St St Y 0
H H Me Me P 1
Ph H Me Me P 1
Nv
R ♦ t R Iff
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H H Me Me I a 1
H H Me Et I a 1
Ph H Me Me I a 1
Ph H Me Et I a 1
H H Me Me I 0 1
H H Me Et I 0 1
Ph H Me Me Br 0 1
Ph H Me Et Br 0 1
79.
With on© exception, series [3] and [4]
are unfortunately incomplete because the diethyl
compounds could not oe obtained crystalline.
Originally it was planned to make more
compounds in series [3] in which n was 1 or 2,
but it was not found possible to make sufficient
amounts of the « and y- hydroxymethylpiperidines
to do this.
The method© for making the agonists
(R « Rf = H) and the antagonists (R « Ph, R « H










where a' « Me or St
(CHa)n.OAc





where R" = Me or St
HI,. (CHa )a. OH




where Ac «= CHa • CO or





where Rf" = Me or Et
81.
The work Is divided into three sections:
I. The synthesis of the appropriate
aminoa1cohol s.
II. Acylation of the aminoalcohols.
































.H + \ / —M#OH—> N. CHa. GHjjOH
0 /
To piperidine (255 g. » 3 mole)
dissolved in methanol (500 ml. ) and cooled in an
ice-bath, ethylene oxide (132 g., 3 mole) was
added at such a rate that the temperature did not
rise above 40°. The mixture was then
refluxed for eight hours and the methanol
distilled off. The residual oil was distilled
under reduced pressure.
a. p. 87®/l5 mm., ng° 1.4808, yield 70% (370 g. )
b) h-pyrroliainoethanol was prepared in
exactly the same way using pyrrolidine (213 g. ,
3 mole) in place of piperidine.
B.p. 73-81°/l5 mm., n»° 1.4710, yield 84$ (294 g. )
8k,
c) 1 -m^f- yi-3-hydroxypi per ia ine.
+ H. COaH + H, CHO. —>
(90%sltn. ) (40; ; sitn. ) I .
I
Me
P~Hydroxypiperi&ine (10,1 g. , 0,1 mole)
was dissolved in a 90% solution of formic acid
(13.0 ml.) and, after the initial exothermic
reaction had subsided, 40% formaldehyde solution
(10.0 ml.) was added [Clarke et al. 1933]• The
mixture was refloxed for three hours and then
cooled*, concentrated hydrochloric acid (10 ml. )
was added and the excess formic acid -
formaldehyde solution was removed by distillation
under slightly reduced pressure. A small
quantity of water was added to the residue and
this was then made alkaline with 25% sodium
hydroxide, extracted with ether, dried, and
distilled.
B.p. Q3°/17 mm., n*° 1.4746, yield 87% (10 g. )
[Biel et al. (1952), B.p. 31°/15 mm.,









P-Hydroxypiperidine (3.3 g. , 0.3 mole)
dissolved in etbanol (10 ml.) was refluxed with
potassium hydroxide (S. 3 g. Analar) and ethyl
iodide (5.2 g. , 0.3 mole) for eighteen hours.
The potassium iodide formed was filtered off and
the filtrate acidified with concentrated
hydrochloric acid, and concentrated to dryness in
vacuo [Biel et al. 1952].
The residue was taken up in the
minimum of 'water, extracted with ether, dried
and distilled.
3.p. 91—2°/12 mm., n* *1.4771, yield 70%
(3 g. ) [Biel et al. 1952), B.p. 93-5°/l5 ram.,
Paul and Tchclitcheff (1945), B.p. 93°/l5 mm.,
n^*l. 4769]
©) : -methyl-y-hydroxyplperialne.
B.p. 90-2°/15 mm., n*°1.4795, yield 53$ (2 g. )
and
f) :. -ethyl-y-hydroxypiperidine.
B.p. 106°/14 ram., n|j*l.4813, yield 58,, (2.5 g. ),
86«







Beecham's Research Laboratories kindly prepared
some ethyl nipecotate (B,p. 100-2°/ll mm.,
nfy 1.4609) by reducing ethyl nicotinate
catalytically.
Lithium aluminium hydride (7.6 g. ,
0.2 mole) suspended in anhydrous ether (250 ml. )
was refluxed for five minutes. The heating was
switched off and ethyl nipecotate (31.4 g. ,
0.2 mole) in anhydrous ether (350 ml, ) added at
such a rate that refluxing continued
spontaneously. The mixture was then refluxed
for six hours.
Water (7 ml.), 10% sodium hydroxide
(20 ml. ) then more water (5 ml. ) was added
carefully in this order to the well cooled
mixture [Micovic and Mihailovic, 1953]. The
residue was removed and the filtrate dried over
anhydrous potassium carbonate. The ether was
removed by distillation and the residue distilled
under reduced pressure.
88.
B.p. 97-100°/0« 7 mm., n*° 1.4960, yield
65;- (lo g. ) [ - oyle et al. (1962), B.p.
93-6°/0.6 mm.]
:-methyl-j3-hydroxymethylpiperidine was
obtained from the 0-hyd.roxymethylpiperidine by
the methou described on page 84.
B.p. 1126/14 mm., n*° 1.4775, yield 55%
(9 g* ) [boyle et al. (1962), B. p. 100°/9 mm.,
ng° 1.4775]
89.
h) I~>othyl-(3-hyu roxym e thyloiper1u iae.
St
Ethyl nipecotate (15.7 g. , 0.1 mole)
and acetic anhydride (15.3 g., 0.15 mole) were
refluxed for three hours. The excess reagent
was removed and the residue distilled under
reduced pressure.
5. p. 126 °/0. 2 mm. , n*° 1.4800, yield 35%
(17 g. ) [Doyle et al» (1962), 3.p. 110®/0.05 mm.,
n»°l. 4808]
The product, *-acetyl ethyl nipecotate
(19.9 g. , 0.1 mole), in anhydrous ether (250 ml.)
was reduced with lithium aluminium hydride
(11.4 g., 0.3 mole) by the method described on
page 87 , whereby M-ethyl-3-hyaroxyraethylpiperidine
was obtained.
5.p. 117V13 mm., n*°1.480S, yield 72%



























Dry hydrogen chloride was "bubbled
through a slurry of L-glutamic acid (147 g. , 1
mole) in ethanol (500 ml.), until all the
L-glutamic acid had dissolved. The solution was
then heated under reflux for an hour. (This is
a modification of the method described by Angier
and Smith, 1955).
The ethanol was distilled under
reduced pressure and water (50 ml. ) added before
it had time to solidify, then cooled and ether
(50 ml.) added. Ammonia (S. <3. =0.88) was added,
with vigorous stirring, until the pH was 9.6*,
during the addition, the temperature was not
allowed to rise above 15°.
The solution was extracted successively
91.
with portions of ether (5 x 100 ml.), and the
ether extracts combined, dried, and the ether
removed under reduced pressure. The residue,
diethyl glutamate, was refluxed with xylene
(500 ml. ) for twelve hours*, then the xylene was
removed under reduced pressure and the residue
was distilled.
B.p. 126~30°/0.5 mm. (m. p. 53°) yield
69£i (108 g. ) [Fischer and Boehner (1911),
m. p. 54° ]
The produce, 2-carboxyethyl-pyrrolid-
5-one, was reduced to cc-hydroxymethylpyrrolidine
with lithium aluminium hydride according to the
method described by Karrer and Portman (1948).
B.p. 96-9°/l4 mm., nj?° 1.4880, yield
52% (36 g. ) [Blicke and Lu (1955), B.p. 96-8°/
14 mm. ]
N-methylation of a-hydroxymethyl-
pyrrolidine v/ith formic acid - formaldehyde was
performed by the method on page 84 , yielding
2^-methyl-a-hydroxymethylpyrrol id ine.
B.p. 71°/14 mm., n£°l.4690, yield 54%
(14 g. ) [Blicke and Lu (1955), B.p. 67-9°/l2 mm.]
3) h-ethyl-a-hyd roxyme thylpyrrolidine.
Ethylation of ct-hyd roxymethyl-
pyrroliaine, using ethyl iodide in ethanolic
92.
potassium hydroxide, was performed as
previously described on page 35.
B.p, 74°/l2 mm* , n*® 1*4726, yield 5 g*
(48%)
93.
k) I' -iso tr.yl -g -hydroxymet hyIpyrro 1 i d ine.
+ CHS ma
in ethanol











To a solution of methylamine in ethanol
(100 ml- , 33% sltn.), cooled in an ice-bath,
dimethyl itaconate (158 g. , 1 mole) was added at
such a rate that the temperature remained
between 5 - 10®. With constant stirring the
mixture was then left for twelve hours at room
temperature. The solvent was removed by
distillation and the residual oil distilled
under reduced pressure.
B. p. Io0-1°/18 mm. , ng51.4740, yield
31% (127 g. ) [Wu and Feldkamp (1951), B.p.
160-1°/18 mm., ng81.4742]
This product, K-methyl-3-car'boxymethyl-
pyrrolid-5~one. was then reduced with lithium
aluminium hydride to N~methyl-g-hydroxymethyl-
pyrrolidine according to the method of Wu and
Feldkamp (1951).
B.p. 99-100°/l7 mm., ng51.4661, yield




This compound was prepared "by exactly
the same method as described on page 93» except
ethylamine was used this time instead of
methylamine.
3.p. 104-6°/l8 ram., ng51.4691, yield
49% (58 g. ) [Wu and Feldkamp (1961), B.p.
110-11 */20 ram., n®51.4693]
95.
II. Ac.ylatlon of the amigoalcohols.
The acyl derivatives prepared were:
(i) Acetyl (when R = H and Rf « H)
(ii) Diphenylacetyl (when R = Ph and Rf = H)
(iii) Benziloyl (when R = Ph and R' » OH ; only
for Beries [1] and [2] ).
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( i) Preparation of acetyl derivatives.
Acetyl derivatives were prepared toy the
action of acetyl chloride on the arainoalcohol
dissolved in dry chloroform.
e# S* The preparation of N-(aeetoxyethyl)-
pjperidlne.
N. (GHs)a.OH + CH3.C0G1 •
y r~
CH3.CO.0. (CHa)a.N
Acetyl chloride (78.5 g. , 1 mole) was
added dropwise, with continuous stirring, to an
ice-cooled mixture of N-piperidinoethanol
(64.5 g. , 0.5 mole) dissolved in dry chloroform.
The product was poured into cold anhydrous ether
(1 litre). The melting point of the hydro¬
chloride, after recrystallisation from ethyl
methyl ketone, was 189°.
This was dissolved in the minimum
quantity of water, made alkaline with sodium
carbonate solution, extracted with ether, dried
with anhydrous sodium sulphate and distilled.
K-(acetoxyethyl)piperidine tooiled at 95°/13 mnu ,
yield 49% (42g. ).





Acetate of Yield m.p. of ester
hydrochloride






N-pyrrolidinoethanol 60 124 91-3/16 2
N-methy1-p-hydroxy-
piperidine 71 140 72/11 3
lx-ethyl-£~hydroxy-



























1. Matkovics et al. (1961) give in.p. of hydrochloride 189°, ester h.p.
72°/2 ram.
2. Matkovics et al. (1961) give m.p. of hydrochloride 128°» ester h.p.
76°/5 mm.
3. Doyle et al. (1961) give ester "b.p. 72°/ll ram.
4. Mikhlina et al. (1960) give m.p. of hydrochloride 179-81®.
5. Renshaw and Cass (1939) give m.p. of hydrochloride 73-4°.
* Indicates that the ester hydrochlorides and the esters were unstable.
In these circumstances the crude ester was used for quaternisation.
98.
(ii) Preparation of dlghenylacc-tyl derivatives.
The diphenylacetyl esters were
prepared by the action of diphenylacetyl chloride
on the aminoalcohol hydrochloride dissolved in
dry chloroform,
e. g. The preparation of N-(dlphenylacetoxyethyl)-
piperidine
\. (CHa)a.OH + (Ca Hs )SGH. GO. CI >
(c6 H5 )3 GH. GO. 0. ( CHs )a . Ii
To an ice-cooled mixture of N-
piperidinoethanol (12.9 g. , 0.1 mole) in ether
(500 ml.), an etherial solution of anhydrous
hydrogen chloride was added dropwise, with
continuous stirring, until the 1-piperidinoethanol
hydrochloride had heen completely precipitated.
This extremely hygroscopic hydrochloride was
immediately transferred to a small wide-mouthed
flask, containing dry chloroform (15 g. ).
Diphenylacetyl chloride (23.05 g. , 0.1 mole) was
added and the mixture heated under reflux for
six hours.
A straw-coloured liquid was obtained.
This was cooled, and poured into anhydrous ether
(500 ml.). The hydrochloride of the
diphenylacetyl derivative which precipitated was
99.
filtered off and recrystallised from ethyl
methyl ketone. It had a melting point of 131°.
The hydrochloride was added to a
solution of sodium hydroxide (50%), extracted
with ether, and the extract dried with sodium
sulphate. The ether was distilled off hut any
attempt to distil the ester caused it to
decompose. The undistilled material was found
to he pure enough for conversion to the
quaternary salt. In other preparations it was
sometimes possible to distil the ester.
Yields and physical constants are shown
in Table
TABLE yvt















piperidine 63 192-3 155-60°/0.1mm. 1,2
N-ethyl-p-hydroxy-




























1. Blel (1962) give m. p. of hydrochloride 193-4°*, ester h.p.
160-3 /0. 06 mm.
2. Doyle et al. (1951) give ester h.p. 155-62°/0.1 mm.
3. Biel et al. (1952) give m.p. of hydrochloride 195-6°", ester h.p.
191-2°/0.18 mm.
4. He£1vain and Rorig (1948) give m.p. of hydrochloride 115-20°.
5. Blicke and Lu (1955) give m.p. of hydrochloride 134-5°.
* See page
101.
(iil) Preparation of the benziloyl derivatives.
The benziloyl esters were prepared from
the aminoethyl chloride hy the method described
by Horenstein and Pahlicke (1938) as modified
by Burtner and Cusic (1943).
e. g. Preparation of Ii-(benzlloyloxyethyl)-
plperidlne.
S-H + CI. (CHa)a.0H-» < N. (CHS )a. OH
J \ / [I]
as hydrochloride




( C6 YLg ) 3 . G ( OH ) . GO. 0. ( CH2 )a . N
Piperidine (35 g., I mole) dissolved
in anhydrous toluene (80 g.) was refluxed with
ethylene chlorohydrin (80.5 g., 1 mole) for three
hours. This was left to cool and N-
piperidinoethanol hydrochloride (I) crystallised
out and was filtered off.
This solid was then dissolved in dry
chloroform (50 g, ), treated dropwise with
thionyl chloride (119 g. , 1 mole), and refluxed
for two hours. The mixture was left to cool and
K-(j3-chloroethyl)piperidine hydrochloride (II)
crystallised out. This was filtered off and was
102.
washed with small amounts of dry chloroform.
The melting point of (II) was 228°. [Stach and
Winter (1962) give 229-30®].
This was dissolved in the minimum
quantity of water, made alkaline with sodium
hydroxide solution (40%), extracted with ether,
dried and distilled. The N-(f3-ehloroethyl)~
piperidine boiled at 70°/14 mm. [Stach and
Winter (1962) record 75®/16 mm,].
This product was dissolved in
iso-propyl alcohol (200 g, ), benzilic acid
(22.83 g. , 0.1 mole) was added, and the mixture
was heated under reflux for four hours.
Anhydrous ether was added to the cooled
solution until it became turbid*, the mixture
was then left and the hydrochloride was found to
crystallise out slowly.
The product was filtered off, but, as
it was extremely hygroscopic, it was not
purified but converted immediately into the base
by adding alkali and extracting with ether.
The extract was dried with anhydrous sodium
sulphate and distilled. The benziloyl ester of
Is-piperidinoethanol boiled at 196-8®/15 mm. ,
yield 28% (94 g. ). [Matkovics et al. (1961)
give 141°/2 mm. ].
The benziloyl ester of N-
pyrrolidinoethanol, as its hydrochloride, was
103.
obtained by the same method in 46$ yield.
The melting point was 95-4® (recrystall!sed
from ethyl methyl ketone).
10U.
III. 2uaterniaa11 on of the aralnoesters.
The method employed was the same for
all the compounds.
The amlnoester (0.01 mole), dissolved
in ethyl methyl ketone, was heated under reflux
with methyl or ethyl halide (0.015 mole) for two
hours. The quaternary ammonium halide
crystallised slowly from the cold solution
(sometimes it was necessary to add anhydrous
ether to encourage crystallisation) and was
filtered off then recrystallised.
The melting points, yields and













H a Me 64 109 ethyl methyl
ketone/ethyl
acetateH H St 58 85




Ph H st 75 141
Ph OH Me 53 110
Ph OH St 69 135-7
„ XXIII
R R' R" M.W.
Percienta&e Found Percentage Reauired.
H I~ G H I~
H H Me 313.2 38.62 6.14 41, 45 38.35 6. 44 40. 52
H H St 327.2 40. 51 6. 50 33. 69 40. 37 6. 73 38,78
Ph H Me 465. 4 56.72 5. 78 27.27 56. 77 6. 06 27.26
Ph H Et 479. 4 57. 81 6. 31 26. 64 57. 61 6. 31 26.47
Ph OH Me 431. 4 55. 48 6. 10 26. 22 54.38 5. 85 26. 36
Ph OH Et 494.4 56.02 6. 02 25. 91 55.86 6.11 25.66
106.
series r si
Ra • C. R *. CO. 0. (CHS )a.K+
R ii
TABLE XXIV





H H Me I 61 63-4 ethyl methyl
ketone/ethyl
acetateH H Et I 70 58




Ph H Et I 59 150
Ph OH Me Br 55 211
Ph OH Et Br 74 200-2
TABLE XXV
R R' R" x" M.W.
Percentage Pound Percentage Reauired
rt
w H Halide C H Halide
H H Me I 299.2 36. 04 6.19 42.73 36.13 6. 06 42.41
H H St I 313. 2 38. 24 6. 36 40. 29 33. 35 6. 44 40. 52
Ph H Me I 450.3 55.54 5. 97 28. 04 56. 01 5. 82 28.18
Ph H Et I 465.4 57. 00 5.90 27. 42 56. 77 6. 06 27. 27
Ph OH Me Br 420. 3 60. 10 5. 91 19.18 60. 00 6. 23 19. 01
Ph OH Et Br 434.4 60. 70 6. 51 18. 57 60. 82 6. 49 18. 39
PABL & XXVI






H H Me Me 0 0 73 155 ethyl methyl
ketone/ethyl
acetateH H Me Et 0 0 52 117—8
Ph H Me Me P 64 186 iso-propyl
alcoholPh H Me St 0 P 53 63-70*d
a H Me Me 0 r 33 169 ethyl methyl
ketone/ethyl
acetateH H Me Et 0 Y 31 242




Ph H Me St 0 Y 48 185
Ph H Et Et
**<•
u Y 23 162
H H Me Me 1 P 85 130~ls ethyl methyl
ketone/ethyl
alcoholPh H Me fee 1 P 76 216
1. Biel (1962) gives 70° decomposes®







Percentage Pound Percentage Reauirec
R R H 0 H I"
H H Me Me 0 8 299. 2 36.03 6. 06 42.79 36,13 6. 06 48. 41
H H Me Et 0 0 313. 2 38.52 6.07 40. 68 38. 35 6. 44 40.52
Ph H Me Me 0 0 -i-O0e 3 55. 88 5.77 28. 41 56. 01 Oa 23.13
Ph H Me Et 0 0 4-5 o* 4 56. 70 6. 33 27. 03 56. 77 6. 06 27. 25
H H MP. Me p Y 299.2 36. 32
.
6. 05 42. 57 36.15 6. 06 42. 41
Ph H Me Me 0 Y 450.3 55. 91 5.75 88. 54 56. OX 5. 82 23. 18
Fh H Me Et 0 Y 46 6# 4 37. 03 6. 02 87. 73 55. 77 6* 06 27. 26
Ph H Et Et 0 Y 479. 4 57. 53 6. 38 26. 22 57. 61 6. 31 86. 47
H H Me Me 1 0 313.2 38. 04 o» 32 40. 19 38. 35 o© 44 40. 52
Ph H Me Me 1 3 466. ^ 56. 68 6. 09 27. 56 56. 77 6® 0Q 27. 26
108.
SERIES f41
R2.C.R'.C0. 0. (CHa ) n X
/ \
TABLE XXVIII
R it R in









n H Me Me 1 a i 74 1251 ethyl methyl
ketone/ethyl
acetateH H Me Et 1 a I 58 165
Fh H Me Me 1 a i 92 179
iso-propyl
alcoholPh H Me Et 1 a I 56 154
H H Me Me 1 P i 23 130 ethyl methyl
ketone/ethyl
acetateH H Me Et 1 3 I - 31 151
Ph H X« Me 1 3 Br 76 148 iso-propyl
alcohol
4 etherPh H Me Et 1 3 Br 61 92s.
1. Renshaw and Cass (1939) give 127-8°.
s. Sealed tube.
TABLE XXIX





Percentage Found Percentage Re
C H Halide C H
H H Me Me 1 a I 299.2 36. 10 5. 83 42. 35 36.13 6. 06
H H Me Et 1 a i 313.2 38. 32 6. 32 40.20 33. 35 6.44
Ph H Me Me 1 a i 450. 3 55. 94 5. 77 23. 04 56. 01 en a CO to
Ph H Me Et 1 a i 465.4 56. 49 5. 66 27. 06 56. 77 6.06
H H Me Me 1 3 i 299.2 36. 22 5.85 42. 29 36.13 6.06
H II Me Et 1 3 I 313.2 38.41 6. 23 40. 46 38.13 6.44
Ph H Me Me 1 3 Br 404.4 62.53 6. 65 20. 16 62. 36 6. 48
Ph H Me Et 1 3 Br 418.4 62.91 6. 52 19. 38 63. 14 6. 74
109.
REFERENCES - CHEMISTRY
Angier, R.B. and Smith, V.K. (1956). J. Org.
Chem.. 21, I5hl.
Biel, J.H. U.S., Patent. 2,995,560, (1962).
Chem.Aha.. 56, lh35e
Biel, J.H., Friedman, H.L., Leiser, H.A. and
Sprengeler, E.P. (1952). J. Araer. Chem. Soc..
ZM 1h85.
Blicke, F.F. and Lu, Chi-Jung. (1955).
J. Amer. Chem._Sojs.. 77, 29.
Burtner, R.R. and Cusic, J.W. (I9U3). J. Amer.
Chem. Soc.. 65, 262,
Clarke, H.T., Gillespie, H.B. and Weisshaus, S.Z,
(1933). J. Amer. Chem. Soc.. 55, J+571.
Boyle, F.P., Brain, E.G. and Mehta, M.D. (1961).
J. Chem. Soc.. 633.
Doyle, F.P., iehta, M.D, and Ward, R. B.P. 886,
437. (1962). Chem. Aba.. lhzk6e.
Fischer, E. and Boehner, R. (1911). Ber..
Mb 1333.
Horenstein, H. and Pahlicke, H. (1938).
llf 165U.
Karrer, P. and Portmann, P. (igkS), Helv.
acta. Chim.. II, 2092.
110.
SSatkovics, B., Foldeak, S,, Porszasz, J. and
Sipos, 0. (I961). Acta. Pharm. Hung..
11, 113.
McElvain, S.M. and Rorig, K. (19^8). J. Amer.
Chem. Soc.. 20, I827.
Micovlc, V.M. and Mihailovic, M.L. (1953).
J. Org. Chem.. 18, H90.
Mikhlina, E., Voroh'eva, V.Y. and Ruhstov, M.V.
(i960). Zhur. Obshchei Khim.. 10, 1885.
Paul, R. and Tchelitcheff, S. (1945). Gomnt.
Rend.. 221. 560.
Renshaw, R.R. and Cass, W.E. (1939). J. Araer.
Chea. Soc.. 6JL, 1195.
Stach, K. and Winter, W. (1962). Arznelmittel-
Fo£§£fc.» IE, 25.
Wu, Y.H. and Feldkamp, R.F. (1961). J. Org.
Chea.. 26. 1519.
AgjfflOWLEDG^M^NT
I wish to express my sincere gratitude
to my supervisor, Dr. E.B. Barlow, for his
constant guidance, invaluable advice and
encouragement throughout this work.
This work was carried out during the
tenure of a University of Edinburgh Faculty
of Medicine Research Scholarship.
